We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00347984
Recruitment Status : Completed
First Posted : July 4, 2006
Last Update Posted : April 10, 2012
Sponsor:
Collaborator:
Information provided by:

June 30, 2006
July 4, 2006
April 10, 2012
December 2005
February 2006   (Final data collection date for primary outcome measure)
Frequency of drop use and/or desire to use; Drop preference
Same as current
Complete list of historical versions of study NCT00347984 on ClinicalTrials.gov Archive Site
Product questionnaire; Symptoms; Corneal and conjunctival staining; Tear film break-up time (TFBUT).
Same as current
Not Provided
Not Provided
 
Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use
The Effect of Systane® Compared to Marketed Artificial Tears on Frequency of Drop Use
The objective of this study was to evaluate the effect of Systane® compared to marketed artificial tears on the frequency of drop use.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double
Primary Purpose: Treatment
Dry Eye
Other: Systane Lubricant eye drops
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
February 2006
February 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Subjects age 18 (minimum); reported history of dry eye syndrome in both eyes; TFBUT ≤ 7 seconds in at least 1 eye at Visit 1; ≥ 1+ fluorescein staining score in any region in at least 1 eye at Visit 1; desire to use an artificial tear substitute for dry eye symptoms at least 4 times per day at Visit 1 and Visit 2.

Exclusion Criteria:

  • Age less than 18 years
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00347984
05-004-09
Not Provided
Not Provided
Not Provided
Not Provided
Alcon Research
ORA, Inc.
Study Director: Mike Christensen Alcon Research
Alcon Research
August 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP